MétaCan
Menu
Retour à la cohorte
Enregistrement W4231749611 · doi:10.1097/01.asw.0000508380.85110.18

US Food and Drug Administration Novel Healthcare Devices and Apps: A Microreview

2016· review· en· W4231749611 sur OpenAlexaboutno aff

Notice bibliographique

RevueAdvances in Skin & Wound Care · 2016
Typereview
Langueen
DomaineHealth Professions
ThématiqueMobile Health and mHealth Applications
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicineFood and drug administrationHealth careAdministration (probate law)Drug administrationDrugMEDLINEMedical emergencyPharmacology

Résumé

récupéré en direct d'OpenAlex

FigureThe advancing array of biomedical technologies developed by medical device manufacturers include, but are not limited to, the use of microchip technology that readily adapts to computer-driven miniature motors, sensors, actuators, and transducers. In addition, these small technologies comprise parts of medical devices, including “flexible robots” and sensors that are woven into fabrics and smart dressings.1,2 It is now commonplace to couple the driver for these devices into “smart phones” or tablets. The miniaturization of computers allows for “point-of-service” application. Cell phones and mobile (handheld) devices are no longer limited to communication; they now incorporate computational devices specifically designed not only to drive but also to control healthcare applications (devices). These small devices now have the capability of using data collected from cameras, ultrasound, and near-infrared scanners. Specifically, in the wound care realm, there are opportunities to monitor wound healing in real time and even measure treatment outcomes. The Food and Drug Administration (FDA) categorizes the devices under the following framework3: Mobile platforms (handheld), commercial off-the-shelf computing platforms, with or without wireless connectivity. Examples include smart phones, tablet computers, or other portable computers. Mobile application (app) is defined as a software application that can be executed (run) on a mobile platform (ie, commercial off-the-shelf) or a web-based software application that is tailored to a mobile platform but is executed on a server. Mobile medical app: For purposes of this guidance, a “mobile medical app” meets the definition of device in section 201(h) of the Federal Food, Drug, and Cosmetic Act and is intended to be used as an accessory to a regulated medical device or to transform a mobile platform into a regulated medical device. The FDA guidance document for medical mobile apps and indications for regulatory approval was updated in February 2015.3 In general, the FDA regulates those apps that meet the definition of a medical device and that pose a risk to patient safety if they do not function as intended. Medical apps that provide medical information or content are generally not required to seek regulatory approval. However, medical apps that incorporate diagnostics or primary prevention and disease prevention recommendations are generally subject to individualized FDA enforcement discretion. If those devices measure healing and/or capture diagnostic images, they can be subject to disclosure in a medical malpractice case, especially if they cause or document a safety risk. The FDA now encourages input about these devices from the end user as well—the patient.4 The application/approval 510(k) process for mobile device and mobile medical app developers is much shorter than the application/clearance process for medical devices, with most 510(k) submissions cleared within 1 year.5 We are beginning to see more handheld wound care diagnostic devices published in our journal and other peer-reviewed media, including the following examples: FDA-approved “Scout”—an image capture device (WoundVision, LLC, Indianapolis, Indiana) to measure wound length and width and wound perimeter.6 A handheld, Portable Real-time Optical Detection Identification and Guide for Intervention (MolecuLight, Toronto, Ontario, Canada) that enables noncontact, real-time, high-resolution visualization and differentiation of key pathogenic bacteria through their endogenous autofluorescence, as well as connective tissues in wounds.7 An ultraportable near-infrared optical scanner has been developed at the Optical Imaging Laboratory that can perform noncontact 2-dimensional area imaging of the wound site.8 This research was supported by the National Institutes of Health (R15CA119253) and Florida International University Division of Research, Miami, Florida. This month’s continuing education article (page 567) gives us a systematic review and meta-analysis on the efficacy of monitoring devices in support of prevention of pressure injuries.Figure

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: aucune
GenreSignal candidat: Synthèse · Signal consensuel: Synthèse
Score de désaccord entre enseignants0,935
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0020,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0010,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,050
Tête enseignante GPT0,470
Écart entre enseignants0,421 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeSans objet
Domainenon disponible
GenreSynthèse

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2016
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueAdvances in Skin & Wound CareMême sujetMobile Health and mHealth ApplicationsTravaux en français237 207